He highlighted that the Union Government is working on bringing back production of Penicillin G in India after three decades. The pharma industry is highly competitive, and companies may engage in mergers and acquisitions to stay ahead. To understand how strong a company is, look at where it stands in the market, and its growth and check if its stock prices have changed recently. Headquartered in Mumbai, Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India. Among these, 6 facilities specialise in manufacturing finished formulations, and one facility focuses on producing Active Pharmaceutical Ingredients (APIs). The company offers a comprehensive range of speciality branded generic products catering to various chronic and acute therapies.

The demand of Generic Medicine in Indian Drugs Market

“Making quality medicines available at affordable prices has been a key challenge. We will reinvigorate the supply of generic drugs. 3,000 Stores under Prime Minister’s Jan Aushadhi Yojana will be opened during 2017.” At Zeelab Pharmacy we offer you with an option to receive genuine and relevant consultation from our team of best doctors and healthcare professionals. You can now buy generic medicines online and at the same time avail reliable and accurate medical information about medicines, illnesses, lab tests, Ayurvedic and over the counter health products. Additionally, Jain points out the absence of provisions for setting maximum retail prices (MRP) for non-scheduled formulations, including generic versions of medicines.

Doctors Should Only Prescribe Generic Drugs Instead Of Brand-Name Medicines : Plea In Supreme Court

• The company specialises in discovering, developing, manufacturing and marketing various branded generic pharmaceuticals, nutritional products, diagnostic tools, and vascular and diabetes devices.
• These stocks are chosen based on their market capitalization, which represents the total value of a company’s outstanding shares.
• Deshpande said that the only difference in pricing is because of the long supply chain and marketing gimmick used by MNCs which result in high prices of branded medicines.
• Many countries across the globe are keen to use more generic drugs in the long run to cut down the cost of healthcare.
• As you may be aware, the European Union’s General Data Protection Regulation (“GDPR”) goes into effect on May 25, 2018.
• All our medicines and healthcare products are manufactured at WHO-GMP certified plants.
• Knowing how to identify generic medicines is important to ensure the most effective treatment at the lowest cost.

Return the watch in the original condition in brand box to avoid pickup cancellation. We will not process a replacement if the pickup is cancelled owing to missing/damaged contents. Return the clothing in the original condition with the MRP and brand tag attached to the clothing to avoid pickup cancellation. We will not process a replacement or refund if the pickup is cancelled owing to missing MRP tag.

Advantage India

India supplied around 45 tonnes and 400 million tablets of hydroxychloroquine to around 114 countries globally. The Indian pharmaceutical industry has seen a massive expansion over the last few years and is expected to reach about 13% of the size of the global pharma market while enhancing its quality, affordability, and innovation. You are not alone if you worry that generic medications are less expensive and could have lower quality. The regulator strives to make generic medications as secure and efficient as brand-name medications.

Pharma’s dirty deals to stall generics

It is important to note that market capitalization in no way guarantees a company’s performance or the returns from its stocks. However, it can be used as a criterion for shortlisting companies from within a sector. Investors should recognize that other factors, such as financial health, management efficiency, and market trends, play crucial roles in determining the actual success of an investment. These stocks are chosen based on their market capitalization, which represents the total value of a company’s outstanding shares. The selection is arranged in descending order, placing the largest companies first and the smaller ones later.

• The HITEC city of Hyderabad serves as the corporate headquarters of the pharmaceutical company Aurobindo Pharma.
• As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines.
• Its vaccine business mainly focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants, toddlers, adolescents, adults and the elderly as part of primary vaccination.
• Return the watch in the original condition in brand box to avoid pickup cancellation.
• The drug prices include marketing and promotional costs which cut down on the public’s wallet.

Lexicare Pharma Pvt. Ltd.

In fact, Regulation 1.5 of the Medical Council Regulations 2002 says that every physician should, as far as possible, prescribe generic medicines. Top 10 Generic Pharma Companies in India – Generic drug companies have become an intimidating segment of the pharmaceutical drug market. A report by Global Data says that Indian generic manufacturers are doing particularly well in the generics marketplace, and more and more companies are moving their manufacturing facilities overseas to cut costs. Generic medicines are usually identical as a proprietary drug that has a brand name because of which the chemical composition of the medicine is sold as. Without any difference, the generic drug is the same in potency, dose, and method of intake, quality, and implications and works the same as the branded medicine. As per Indian household, the term ‘generic’ implies the drug is a cheaper, less effective and duplicate version of the brand name product.

India Formulations

For a generic manufacturer, no such investment is required — not in development and not in marketing. The medicine’s formula is known, the clinical trials are complete; the generic maker’s only requirement is to demonstrate to regulators that its version is as good and effective in humans as the original. According to a recent EY FICCI report, there has been a growing consensus over providing new innovative therapies to patients. Indian pharmaceutical market is estimated to touch US$ 130 billion in value by the end of 2030.

US generic drug price-fixing conspiracy jolts Indian pharma companies

The objective of the scheme is to transform Indian pharmaceuticals sector from cost-based to innovation-based growth by strengthening the research infrastructure in the country. The scheme aims to promote industry-academia linkage for R&D in priority areas and to inculcate the culture of quality research and nurture the pool of scientists. This is expected to lead to sustained global competitive advantage and contribute to quality employment generation in the country. As per the FICCI Report on Indian pharma industry (2021), India’s pharma industry has demonstrated a compounded growth rate of (CAGR) of about 11% in the domestic market, while the exports have registered a 16% growth over the last two decades. The domestic market has grown at a pace similar to the gross domestic product (GDP); the overall growth is reportedly driven by the industry’s remarkable steps in supplying generic formulations to global markets.

Indian generic drug firms – pharma MNC patent fight to determine price of medicines

Also, enhancing accessibility to healthcare services and growing healthcare awareness among the public propel the pharma industry growth. Indian drugs are exported to more than 200 countries in the world, with US being the key market. Generic drugs account for 20% of the global export in terms of volume, making the country the largest provider of generic medicines globally. Indian drug & pharmaceutical exports stood at US$ 25.36 billion in FY23, US$ 24.60 billion in FY22 and US$ 24.44 billion in FY21. Market size of India pharmaceuticals industry is expected to reach US$ 65 billion by 2024, ~US$ 130 billion by 2030 and US$ 450 billion market by 2047.

Most Active Stocks

50% of people prefer to purchase generic over branded medicines while 47.8% believe branded drugs are more effective than generic. On April 2017, the Medical Council of India released a notification which stated it is mandatory for the physicians to prescribe the drugs by using generic names. The infusion of generic substitution is supported by health authorities in several developed countries and why it is important to conduct bioequivalence tests and prescribing drug spending. Such requirements might raise the generic drugs prices a bit but is useful in lowering the overall healthcare expenses. Somehow these practices will also combat with the distrust for the generic medicines amongst people who perceive such drugs as of inferior quality and counterfeit of the branded drug. The foremost thingabout generic pharmaceuticals is that they are developed with same chemicalcompositions as the brand medicines.

Dr. Sujit Paul – Group CEO – Zota Healthcare Ltd., leads the domestic and international businesses. He has the unique distinction of serving as a consultant & advisor to multiple International Beauty & Retail brands. The initiative with will introduced home town Surat at the COCO store in PAL and will have a 24 x7 access for customers. To begin with in the initial stage only OTC products are dispensed, but going forward will start dispensing medicines as well. Big Pharma has been using what is called “pay-for-delay” agreements, in which generic companies collude to keep their low-cost medications out of the market for specified terms in return for compensation of some kind or the other.

FDA takes several actions to ensure safety and quality before and after a new or generic medicine is marketed. The only retail chain in the country to have 98% own products sold from the store. This reinsures that high quality products are given to customers at an affordable price. Within a short span from its inception, DavaIndia generic pharmacy has instituted more than 600 retail franchise stores across the length and breadth of India with more than 30 lakh happy customers.

According to the government data, the Indian pharmaceutical industry is worth approximately US$ 50 billion with over US$ 25 billion of the value coming from exports. Indian pharmaceutical industry is known for its generic medicines and low-cost vaccines globally. Transformed over the years as a vibrant sector, presently Indian Pharma ranks third in pharmaceutical production by volume. The Pharmaceutical industry in India is the third largest in the world in terms of volume and 14th largest in terms of value.

• The only retail chain in the country to have 98% own products sold from the store.
• The Indian pharmaceutical industry ranks third globally in terms of production volume and has seen remarkable growth with a CAGR of 9.43% over the past nine years.
• The oldest business in India, Zydus Cadila Healthcare rose to prominence as a top producer of pharmaceutical, diagnostic, herbal OTC, and skincare products.
• India is the 3rd largest producer of API accounting for an 8% share of the Global API Industry.
• Besides physical stores, Medkart helps customers buy generic medicines online in India through its iOS and Android apps.
• In less-educatedcountries, people have been habitual to one set of medicines they believe couldwork in certain health conditions.
• Generic drugs tend to costless than their brand-name counterparts because generic drug applicants do nothave to repeat animal and clinical (human) studies that were required of thebrand-name medicines to demonstrate safety and effectiveness.
• In return, Novartis agreed not to launch its own authorised generic of Exforge during a six-month period of exclusivity that the Par generic automatically secures as the first copycat version of the Novartis drug.

Yasmin Tablets Specific Drug

The generic manufacturer often gives huge trade discounts but fails to reach the buyer. A chemist will always push medicines that offer more margin even if the generic medicine of that company remains higher than other generic medicines. According to study, the Indian generic drugs market stood at USD 24.53 billion in 2022 and is expected to grow at a steady compound annual growth rate (CAGR) of 6.97% during the forecast period.

About 500+ different APIs are manufactured in India, and it contributes 57% of APIs to prequalified list of the WHO. On the orange earnings per share line, the circles plot the sum of the trailing 4-quarters earnings. The Evaluation view is composed of a stock chart and the stock-specific data in the Details Tab. This view efficiently combines the key stock information you need to validate your decision to buy or sell or to commit to further research. We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.

The petitioner also cites a recent Supreme Court judgment that raised concerns about the manipulation of prescriptions for personal gain, such as receiving gifts and incentives from pharmaceutical companies. Such practices can drive up drug costs, affecting the public negatively by creating a ‘perpetual publicly injurious cycle’. But, the lack of a robust system to enforce these regulations through disciplinary proceedings, surprise checks of prescriptions, and regular prescription audits has hindered their practical implementation, leaving them confined to legal frameworks. In addition to the price factor, the PIL stresses the urgent need for effective enforcement mechanisms. The petitioner contends that the existing regulations, such as the Indian Medical Council (Professional Conduct, Etiquette, and Ethics) Regulations, 2002, emphasise the importance of prescribing drugs using their generic names. Legalizing generic medications lowers costs and increases access to inexpensive medication for more individuals.

• Krka Pharmaceutical comes in the list of top generic pharma companies in India.
• Government of India has recently launched the National Policy on Research and Development (R&D) and Innovation in Pharma-MedTech Sector and the Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP).
• The infusion of generic substitution is supported by health authorities in several developed countries and why it is important to conduct bioequivalence tests and prescribing drug spending.
• Such deals involving Indian generic makers, too, are common in the US, where even an iconic Cipla has been named in these anti-trust cases lawsuits.
• According to a recent EY FICCI report, there has been a growing consensus over providing new innovative therapies to patients.
• Moreover, the proposed US Biosecure Act is an important factor for the Indian pharmaceutical industry.
• “Real-time demand forecasting and automation can help optimise RM and PM inventories, while advanced QC techniques can reduce delays,” he said.

Cytonova Labs International Private Limited

• With coronavirus cases increasing, several more of the big India-based healthcare firms which make much of the world’s pharmaceuticals are expected to launch competing versions of remdesivir, the only major treatment so far approved for COVID-19.
• Evaluate the healthcare infrastructure in India as it directly impacts the pharmaceutical industry.
• With 14 manufacturing facilities in four countries and 4 R&D centres spanning across GPL and GLS, we work relentlessly towards improving the quality of life of patients across the globe.
• Transitioning to a pivotal role within Zota Healthcare, he undertook the critical task of sourcing products from reputable manufacturers.
• Giving you an example of a generic drug is generic drug for diabetes is metformin.
• Indian drug & pharmaceutical exports stood at US$ 25.36 billion in FY23, US$ 24.60 billion in FY22 and US$ 24.44 billion in FY21.

Its product range includes a wide array of multi-speciality drugs, vitamins and treatments for conditions such as vertigo, epilepsy, hypothyroidism, migraine and depression. The company’s major markets are present in Western Europe, Australia, Japan, New Zealand, Canada and China. Tradeindia has been doing great work in B2B segment, its so much easy to reach potential buyers through their portal and App.

Moreover, it owns and manages multiple multi-speciality hospitals and super-speciality centres across India. These hospitals offer tertiary and quaternary healthcare services, focusing on areas such as cardiac care, cancer treatment, orthopaedics, neurosciences, renal care, gastroenterology, mother and child care, and kidney and liver transplants. Additionally, the company supplies pharmacy items like medical consumables and drugs. Operating since 1950, Pfizer Limited is a pharmaceutical company that manufactures, markets, trades and exports pharmaceutical products. It operates its manufacturing facility in Goa and collaborates with various third-party manufacturers across India. In view of the above, Department of Pharmaceutical has recently unveiled the PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) scheme with a budget outlay of Rs. 5000 crores.

Also, the pharmaceutical industry has shown tremendous progress and adapted to a changing environment which will help in achieving more success in generic drugs export from India. Furthermore, the Covid-19 pandemic has boosted the exports of generic medicines to a great extent, the developed and developing world are concerned about the high costs of patented medicines and looking for cheaper alternatives. Many countries across the globe are keen to use more generic drugs in the long run to cut down the cost of healthcare. This scheme is currently running in each state of India with its high popularity among the people with average to low-income categories providing the public access to affordable branded medicines.

Yes, The generic medicines have similar efficacy and therapeutic value as that of the branded medicines. Government Patent Law do not allow a generic medicine or medicine to look exactly like other medicines already on the market. Generic medicines and brand-name medicines share the same active ingredient, but other characteristics, such as colors and flavourings, that do not affect the performance, safety, or effectiveness of the generic medicine, may be different. Illegitimate drugs have been a challenging issue for India over quite a period of time.

Get live Share Market updates, Stock Market Quotes, and the latest India News … Read More and business news on Financial Express. Medkart, another such startup, has a wide range of molecules across the spectrum and ends up with an average saving of 73% for its chronic customers. On average, annually ₹10,000 is saved by a chronic customer at Medkart, claims the company. Sources had told Reuters that the first batch of 10,000 vials had been printed with a price of 4,000 rupees, 800 rupees below the cheapest option, launched by European competitor Mylan this week.

Centrum’s report highlights that government initiatives like the PLI scheme and Bulk Drug Parks will boost India’s pharma sector, with US$ 353.4 million (Rs. 3,000 crore) allocated to enhance production and competitiveness. Exports of drugs and pharmaceuticals recorded a strong y-o-y growth of 9.7% during April-March FY24. India’s drugs and pharmaceuticals exports stood at US$ 27.82 billion in FY24 (April-March). The biosimilars market in India is estimated to grow at a compounded annual growth rate (CAGR) of 22% to become US$ 12 billion by 2025. “Every registered medical practitioner should prescribe drugs using generic names written legibly and prescribe drugs rationally, avoiding unnecessary medications and irrational fixed-dose combination tablets.”

Another issue is with the counterfeit medicines sellers who operate at the retail level and procure the substandard medicines from dubious suppliers. Also, many fraud chemist shops sell the counterfeit drugs illegally using the name of a pharmaceutical company that remains completely unaware of the incident. While fighting this issue is beyond the scope of a pharma company, it is very important that it is stopped immediately since it ruins the reputation of that particular pharma company. The current market size of the medical devices sector in India is estimated to be US$ 11 billion and its share in the global medical device market is estimated to be 1.5%.

There are plenty of generic medical stores online where you can get popular generic drugs. Dr. Arunish Chawla, Secretary; Dept. of Pharmaceuticals gave a detailed presentation on the PLI scheme of the Union Government. He said that the drug and pharmaceutical industry in India witnessed a 12% compound annual growth rate (CAGR) in the last 10 years.

The government has set ambitious target to boost the medical devices industry in India, aiming to elevate it from its current US$ 11 billion valuation to US$ 50 billion by 2030. Presently, over 80% of the antiretroviral drugs revolade price in singapore used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms. India is rightfully known as the “pharmacy of the world” due to the low cost and high quality of its medicines.

Torque has taken a huge leap in terms of production, positioning, and presence globally and ultimately has come up as the fastest-growing pharmaceutical company. Through research and development activities, their expert team is always committed to finding better alternatives to more expensive and less feasible generic products, which can be mass-produced for the benefit of entire mankind at affordable rates. In three years, Generic Aadhaar has expanded its presence to more than 150 cities including rural as well as urban areas of India.

Offered drugs by generic pharmaceutical companies are given under the prescription of the specialist. They are involved in Manufacturing, Supplying, and  Exporting generic pharmaceutical medicines all over India. The Jan Aushadhi initiative will make available quality drugs at affordable prices through dedicated stores selling generic medicines which are available at lesser prices but are equivalent in quality and efficacy as expensive branded drugs. The low cost of generics is an alternative to branded drugs and hence generics dominate, making up for 70 to 80% of the retail market. As India’s population grows, especially the aging population has significantly increased the demand for generic medicines on account of their affordability and effectiveness, which is same as branded medicines. The short expiration and gap between re-filing of the new drug encourages various companies to produce generic drugs owing to rise in competition which further reduces the generic drugs prices.

Leading generic drug manufacturers are spending heavily on research and development projects to create FDA-approved drugs that are safe, effective, and patentable. They are also focused on developing original products using the re-innovation business model, which involves enhancing existing product properties, swapping out new components, changing their configuration, and employing new technology platforms. Major segments of the Pharmaceutical Industry include generic drugs, bulk drugs, vaccines, Over-The-Counter (OTC) medicines, biosimilars and biologics. There are 500 Active Pharmaceutical Ingredient (API) manufacturers contributing about 8% in the global API Industry.

For instance, in the 2022 ranking by Generic Bulletin, the top slots are occupied by Sandoz (with a turnover $9. 63 billion), Teva of Israel ($8.98 billion), Pfizer ($8 billion) and Viatris of the US ($6.97 billion). Sun Pharma ($4.83 billion) and Aurobindo ($3.16 billion) are the only two Indian companies to make the cut to the top 10. There are, of course, other Indian entities lower down on the list, but the composition reflects the changed realities of the pharma industry, where the generic business is closely controlled by the innovator companies. The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry.

Meanwhile, the global market size of pharmaceutical products was estimated to cross over the US$ 1 trillion mark in 2023. Now you can save up to 90% on your medicine bills by purchasing lower price medicine through Zeelab Pharmacy’s online medical store nearby without compromising on the quality. This initiative taken up by Zeelab Pharmacy will benefit you by reducing your healthcare budget and minimising the overall cost of your medical treatment. Zeelab Pharmacy was incepted to provide you with affordable quality medicine through its dedicated sales outlets along with online medicine delivery across the country.